C07D/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group. para evaluar los efectos de la administración intravenosa de un antagonista selectivo de oxitocina (Barusiban) y de un antagonista mixto de. ESTOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE OXITOCINA , POR LO QUE SON UTILES EN EL TRATAMIENTO DE.
|Published (Last):||7 November 2018|
|PDF File Size:||10.83 Mb|
|ePub File Size:||4.16 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf].
For these items you should use the filters and not add them to your search terms in the text field. Trials with results Trials without results Clear advanced search filters.
Review by the Competent Authority or Ethics Committee in the country concerned. EU Clinical Antagonisgas Register.
Both Female Only Male Only. IMP with orphan designation in the indication. Trials with results Trials without results.
Clear advanced search filters. Date on which this record was first entered in the EudraCT database:. A randomised, double-blind, parallel groups, placebo-controlled, multi-centre study assessing the effects of a selective oxytocin antagonist barusiban and a mixed oxytocin antagonist — vasopressin V1a antagonist atosiban administered intravenously on luteal phase uterine contractions in oocyte donors supplemented with vaginal progesterone.
The IMP has been designated in this indication as an orphan drug in the Community. Committee on Advanced therapies Oxitocna has issued a classification for this product.
Combination product that includes a device, but does not involve an Advanced Therapy. Co-adjuvant therapy in the luteal phase to facilitate implantation and pregnancy in women undergoing assisted reproductive technologies i.
Atosiban | definition of atosiban by Medical dictionary
Enfermedad cardiaca grave actual conocida 4. Endometriosis conocida de estadio I-IV 8. Hemorragia vaginal no diagnosticada Lactancia materna actual Hipersensibilidad a cualquier principio activo o excipiente contenido en los medicamentos. The trial involves single site in the Member State concerned. Definition of the end of the trial and justification oxitlcina it is not the last visit of the last subject undergoing the trial.